Company Filing History:
Years Active: 2008
Title: The Innovations of Timothy W. Higgenbottam
Introduction
Timothy W. Higgenbottam is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of medical research, particularly in the area of endothelin-1 synthesis. His work has implications for treating diseases associated with excess production of this peptide.
Latest Patents
Higgenbottam holds a patent for "Inhibitors of endothelin-1 synthesis." This patent describes sequences in human preproendothelin-1 mRNA that can be targeted by antisense oligonucleotides to inhibit the synthesis of endothelin-1. The inhibition of endothelin-1 synthesis may be utilized to treat various diseases where its overproduction is a contributing factor to the symptoms.
Career Highlights
Timothy W. Higgenbottam is associated with William Harvey Research Limited, where he continues to advance his research and innovations. His work is pivotal in understanding the mechanisms of endothelin-1 and its role in various health conditions.
Collaborations
Higgenbottam has collaborated with esteemed colleagues such as Roger Corder and Adrian P. L. Smith. These collaborations have further enriched his research and contributed to the development of effective therapeutic strategies.
Conclusion
Timothy W. Higgenbottam's contributions to the field of medical research, particularly through his patent on endothelin-1 synthesis inhibitors, highlight his role as an influential inventor. His ongoing work continues to pave the way for innovative treatments in medicine.